19 Japanese companies form Japan Microbiome Consortium (JMBC)

Some of the companies are Ajinomoto, Astellas Pharma, LSI Mediens, Otsuka Pharmaceutical, Ono Pharmaceutical Industry, Kyowa Hakko Kirin, JSR, Shionogi Pharmaceutical, Shiseido, Daiichi Sankyo, Taisho Pharmaceutical, Dainippon Sumitomo, Mitsubishi Tanabe Pharma, DNA chip laboratory, Japan Tobacco Industry, Fuji Rebio, Mitsubishi Chemical, Morishita Junkan, and Urban Innovation Institute, Osaka (secretariat). JMBC will address the analysis of microbial specimens in feces, skin, and oral mucosa of healthy Japanese.

Nikkei Biotech news release, May 24, 2017

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny